Angelo Antonini (University of Padova, Veneto, Italy), one of our valued European editorial board members, discusses impulse control disorders in patients with Parkinson’s disease including findings related to these behaviours in the Parkinson’s Disease Real-World Impact Assessment (PRISM) study.
Questions
1. What are the major impulse control disorders seen in patients with Parkinson’s disease and what is their prevalence? (0:05) 2. Could you tell us a little about the Parkinson’s Disease Real-World Impact Assessment (PRISM) Study and its findings in terms of impulse control behaviours? (1:59)
Also see linked video: Angelo Antonini, EAN 2020 – Definition and Management of Advanced Parkinson’s Disease
Speaker disclosure: Angelo Antonini has received honoraria for consultancies, advisory boards and/or speaker activities from: AbbVie, Bial, Boehringer Ingelheim, General Electric, NeuroDerm, UCB and Zambon. He has received research support from: Chiesi, Lundbeck, AbbVie, Horizon 2020 and MIUR.
Support: Interview and filming supported by Touch Medical Media.
Filmed at the 6th Congress of the European Academy of Neurology (EAN) and 1st EAN Virtual Congress, May 2020.
